Lysozyme is secreted in large quantities in human airways (10-20 mg/day), w
here it helps to defend against bacterial and fungal infection. Lysozyme ex
pression is restricted to the serous cells of the submucosal glands, which
also express high levels of cystic fibrosis transmembrane conductance regul
ator (CFTR) chloride channels. It is often assumed that mucus secretion in
human airways is coupled to anion secretion through CFTR Cl- channels locat
ed in the apical membrane. Therefore, a defect in CFTR function could cause
abnormal mucus secretion leading to persistent bacterial infection and inf
lammation of the airways. In this study we measured simultaneous secretion
of lysozyme and Cl- from human airway epithelial serous cells. Secretion of
lysozyme was measured by a turbidimetric assay that relies on the ability
of lysozyme to disrupt the wall of the bacterium Micrococcus lysodeikticus,
thus causing a fall in the optical density of the sample. Secretion of Cl-
was measured as short-circuit current in a modified Ussing chamber. Activa
tion of Cl- secretion by stimulation of cAMP- or Ca2+- dependent pathways c
aused comparable increases in lysozyme secretion. Similarly, blockers of Cl
- secretion, such as diphenylamine-2-carboxylate (DPC), also reduced lysozy
me secretion. However, while treatment of airway submucosal gland cells wit
h antisense oligonucleotides directed against CFTR reduced Cl- secretion, i
t had no significant effect on the total amount of lysozyme secretion. Thes
e results suggest a role for functional CFTR in regulation of lysozyme secr
etion in human airways.